Information on research, events, activities, and news from the T1D community across Canada.
The development of encapsulation technologies to treat insulin-dependent diabetes has been at the forefront of type 1 diabetes (T1D) research in North...Read More
We sat down with our JDRF Marketing & Communications summer student, Evelyn Riddell, who lives with type 1 diabetes (T1D) to get her quick tips on how to drink responsibly with T1D.
The Environmental Determinants of Diabetes in the Young (TEDDY) is following more than 7,000 at-risk children from infancy to 15 years of age to determine the causes of T1D.
Evelyn, our Marketing Communications Assistant for the summer, was featured in the latest bra campaign, and the T1D community is loving it!
Imagine an automated insulin delivery system that is able to connect with other devices seamlessly. A state-of-the-art, tubeless technology that provides continuous insulin therapy, operates on its own platform and publishes its own communication protocol.
Researchers at Oxford University (UK) are offering powdered insulin to babies at high risk of developing type 1 diabetes (T1D) with the hope of training their immune systems to tolerate the insulin they produce, thereby offering life-long protection against the disease.
JDRF has joined forces with Danish biotech company, Gubra, to develop a glucose-responsive insulin (GRI) as a treatment for people with insulin-dependent diabetes.
JDRF's leadership was highlighted at the American Diabetes Association's 78th Scientific Sessions.
How to navigate BBQ season with type 1 diabetes.
For Canadian business, philanthropic efforts are the best way to engage employees and induce positive culture.
Why carbohydrate counting should be explicitly allowed for Disability Tax Credit eligibility. A joint submission with Diabetes Canada.